Pulmatrix, Inc. (PULM) |
| 2.33 -0.02 (-0.85%) 01-13 16:00 |
| Open: | 2.35 |
| High: | 2.38 |
| Low: | 2.29 |
| Volume: | 5,762 |
| Market Cap: | 9(M) |
| PE Ratio: | -1.36 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 4.94 |
| Resistance 1: | 3.87 |
| Pivot price: | 2.31 |
| Support 1: | 2.15 |
| Support 2: | 1.79 |
| 52w High: | 10.4 |
| 52w Low: | 2.146 |
Financials
| EPS | -6130000.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | -207.00 |
| Return on Assets (ttm) | 100.0 |
| Return on Equity (ttm) | -47.1 |
Company news
Thu, 18 Dec 2025
Pulmatrix (PULM) Adjusts Merger Agreement with Cullgen, Explores New Options - GuruFocus
Thu, 18 Dec 2025
Pulmatrix, Inc. Announces Waiver Agreement in Merger with Cullgen - TradingView — Track All Markets
Thu, 18 Dec 2025
Pulmatrix and Cullgen waive exclusivity while awaiting China approval - Investing.com
Thu, 18 Dec 2025
Pulmatrix and its merger partner start scouting other deals amid delay - Stock Titan
Thu, 16 Oct 2025
Pulmatrix Announces Third Quarter 2025 Financial Results and Divestment Plan for Migraine and Inhalation Assets - PR Newswire
Fri, 21 Mar 2025
Pulmatrix Announces Year-End and Fourth Quarter 2024 Financial Results and Divestment Plan for Assets - PR Newswire
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
